These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 9301312)

  • 1. [Current advance of blood preservation--development and clinical application of additive solutions for preservation of red blood cells and platelets].
    Yasutake M; Takahashi TA
    Nihon Rinsho; 1997 Sep; 55(9):2429-33. PubMed ID: 9301312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pathogen inactivation on the storage lesion in red cells and platelet concentrates.
    Seghatchian J; Hervig T; Putter JS
    Transfus Apher Sci; 2011 Aug; 45(1):75-84. PubMed ID: 21782517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical implications of red blood cell and platelet storage lesions: an overview.
    Solheim BG; Flesland O; Seghatchian J; Brosstad F
    Transfus Apher Sci; 2004 Dec; 31(3):185-9. PubMed ID: 15556465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of additive solutions for platelets.
    Alhumaidan H; Sweeney J
    J Clin Apher; 2012; 27(2):93-8. PubMed ID: 22298435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of additive solutions on platelet biochemistry.
    Holme S
    Blood Cells; 1992; 18(3):421-30; discussion 431-4. PubMed ID: 1286196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current concepts of blood transfusion.
    Valeri CR
    J Oral Surg; 1977 Sep; 35(9):707-12. PubMed ID: 267750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current methods in blood preservation: recovery of blood components using a multi-bag system].
    Bergmann H; Blauhut B; Gassner W; Haider M
    Wien Med Wochenschr; 1991; 141(21):485-92. PubMed ID: 1781176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet additive solutions: a future perspective.
    van der Meer PF
    Transfus Clin Biol; 2007 Dec; 14(6):522-5. PubMed ID: 18420439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Storage of buffy-coat-derived platelets in additive solutions: in vitro effects on platelets stored in reformulated PAS supplied by a 20% plasma carry-over.
    Sandgren P; Mayaudon V; Payrat JM; Sjödin A; Gulliksson H
    Vox Sang; 2010 Apr; 98(3 Pt 2):415-22. PubMed ID: 19788514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes of the functions and activities of blood components--red blood cells, platelets and coagulation factors--during storage].
    Sasakawa S
    Rinsho Byori; 1991 Mar; Suppl 88():105-15. PubMed ID: 1856959
    [No Abstract]   [Full Text] [Related]  

  • 11. Current and future cellular transfusion products.
    Gelderman MP; Vostal JG
    Clin Lab Med; 2010 Jun; 30(2):443-52. PubMed ID: 20513562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progress in transfusion for storage of platelets].
    Cazenave JP; Isola H; Gachet C; Aleil B
    Transfus Clin Biol; 2005 Jun; 12(2):226-9. PubMed ID: 15950893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a combined storage medium for 7-day storage of platelet concentrates and 42-day storage of red cell concentrates.
    Heaton WA; Holme S; Keegan T
    Br J Haematol; 1990 Jul; 75(3):400-7. PubMed ID: 2117465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo effects of potassium and magnesium on storage up to 7 days of apheresis platelet concentrates in platelet additive solution.
    Diedrich B; Sandgren P; Jansson B; Gulliksson H; Svensson L; Shanwell A
    Vox Sang; 2008 Feb; 94(2):96-102. PubMed ID: 18034788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The new generation of platelet additive solution for storage at 22 degrees C: development and current experience.
    Ringwald J; Zimmermann R; Eckstein R
    Transfus Med Rev; 2006 Apr; 20(2):158-64. PubMed ID: 16565028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo evaluation of apheresis platelets stored for 5 days in 65% platelet additive solution/35% plasma.
    Vassallo RR; Adamson JW; Gottschall JL; Snyder EL; Lee W; Houghton J; Elfath MD
    Transfusion; 2010 Nov; 50(11):2376-85. PubMed ID: 20497516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An approach to prevent the severe adverse events associated with transfusion of FDA-approved blood products.
    Valeri CR; Ragno G
    Transfus Apher Sci; 2010 Jun; 42(3):223-33. PubMed ID: 20392670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of optimal techniques for cryopreservation of human platelets. I. Platelet activation during cold storage (at 22 and 8 degrees C) and cryopreservation.
    Gao DY; Neff K; Xiao HY; Matsubayashi H; Cui XD; Bonderman P; Bonderman D; Harvey K; McIntyre JA; Critser J; Miraglia CC; Reid T
    Cryobiology; 1999 May; 38(3):225-35. PubMed ID: 10328912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel platelet storage conditions: additive solutions, gas, and cold.
    Capocelli KE; Dumont LJ
    Curr Opin Hematol; 2014 Nov; 21(6):491-6. PubMed ID: 25144411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buffy-coat platelet variables and metabolism during storage in additive solutions or plasma.
    Zhang JG; Carter CJ; Culibrk B; Devine DV; Levin E; Scammell K; Weiss S; Gyongyossy-Issa MI
    Transfusion; 2008 May; 48(5):847-56. PubMed ID: 18298601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.